Articles about Product Safety

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

California Trim Clinic Explains the Smarter Safer Path to Peptide Therapy

Today 21:17 EST

Via PRUnderground

New Moment of Clarity Resource Examines How Insurance Covers Ketamine Therapy

Today 19:42 EST

Via Press Advantage

AXSM Stock Rises After Analyst Hikes Price Target On Auvelity Drug Optimism ↗

Today 18:39 EST

Via Stocktwits

Las Vegas Eye Institute Introduces Ray-Traced LASIK: A New Era of Personalized Vision Correction

Today 15:29 EST

Via Press Advantage

Disc Medicine, Sanofi, Eli Lilly Shares Slip On Reports Of FDA Increasing Review Time For Drugs Granted Priority Review Vouchers ↗

January 15, 2026

Via Stocktwits

The New Diagnostic Sentinel: Samsung and Stanford’s AI Redefines Early Dementia Detection via Wearable Data

Today 15:18 EST

Via TokenRing AI

Prediction Markets Hit the Big Leagues: Kalshi Secures $1 Billion at $11 Billion Valuation to ‘Financialize Everything’

Today 15:04 EST

Via PredictStreet

Why ImmunityBio Stock Is Skyrocketing Again Today ↗

Today 14:05 EST

Via The Motley Fool

Disc Medicine Analyst Remains Confident In Rare Disease Drug Despite FDA Action ↗

Today 13:34 EST

Via Benzinga

ImmunityBio Stock Soars On Cancer Trial Progress, FDA Timeline ↗

Today 12:52 EST

Via Benzinga

NVS Stock Rises After FDA Grants Breakthrough Therapy Designation For Autoimmune Disorder Treatment ↗

Today 12:26 EST

Via Stocktwits

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Today 12:26 EST

Via Newsfile

The Truth Engine: How Prediction Markets Became the New Foundation for Global Capital

Today 11:47 EST

Via PredictStreet

Kaplan Fox & Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations

Today 11:30 EST

Via NewMediaWire

Kaplan Fox & Kilsheimer LLP is Investigating Aquestive Therapeutics, Inc. (AQST) for Potential Securities Law Violations

Today 11:30 EST

Via TheNewswire.com

S&P 500 Ascends to Historic Peaks: Stimulus and AI Rebound Fuel January Rally

Today 10:38 EST

Via MarketMinute

Lululemon at the Crossroads: Analyzing the 2026 Leadership Crisis and the Post-Sun Choe Era

Today 9:47 EST

Via Finterra

The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026

Today 9:40 EST

Via Finterra

Why This Horrible Ford Record Is Important for Investors ↗

Today 9:25 EST

Via The Motley Fool

Why Did ATOS Stock Jump 10% In Pre-Market Today? ↗

Today 6:14 EST

Via Stocktwits

Global Development Accelerates: Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Granted Fast Track Designation by FDA

January 15, 2026

Via Newsfile

Moonkie Redefines Toddler Mealtime with Launch of Award-Nominated Stainless Steel Silicone Suction Bowl

January 15, 2026

Via Get News

Baskin Aesthetics Reveals Insights on Bioidentical Hormone Therapy Following Recent FDA Updates on Menopausal Treatments

January 15, 2026

Via Press Advantage

Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation

January 15, 2026

Via MarketMinute

A US Startup Achieves Rapid Business Growth by Purchasing Toptrue Insulated Water Bottles

January 15, 2026

Via AB Newswire

Top 8 Huber Needle Manufacturers and suppliers in China 2026

January 15, 2026

Via AB Newswire

Scientific Instruments Shares How Ignoring Magnaflux Equipment Repairs Can Lead to Missed Defects and Costly Recalls

January 15, 2026

Via ReleaseWire

Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026 ↗

January 15, 2026

Via Benzinga

OS Therapies Bone Cancer Trial Data Strengthens FDA Case ↗

January 15, 2026

Via Benzinga

The Execution Engine: How Merck is Dominating the 2026 Pharma Landscape

January 15, 2026

Via MarketMinute

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.